Company / Current Assets
Ovid Therapeutics Inc. Current Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$74.4M
FY2025
5-year range
$55.9M / $131.4M
FY2022-FY2025
Trend
+32.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 2 years of decline, reaching $74M.
Based on SEC 10-K filings.
$74M in FY2025 with a 3-year CAGR of -17.3%.
Declined from $110M to $74M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -17.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -17.3%, indicating a declining trend.
- In FY2025, current assets increased 32.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.4M | +32.9% |
| FY2024 | $55.9M | -49.0% |
| FY2023 | $109.6M | -16.6% |
| FY2022 | $131.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026